Galapagos has filed a patent for salts of Compound 1, useful in treating various conditions like inflammatory diseases, autoimmune diseases, and allergies. The claim specifies a pharmaceutically acceptable salt of a compound according to Formula (I). GlobalData’s report on Galapagos gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Galapagos, Peptide pharmacophores was a key innovation area identified from patents. Galapagos's grant share as of January 2024 was 32%. Grant share is based on the ratio of number of grants to total number of patents.
Pharmaceutical salt for treating inflammatory, autoimmune, and proliferative diseases
The patent application US20230406857A1 discloses a series of claims related to pharmaceutically acceptable salts of a compound according to Formula (I). These claims include the formation of specific salts, solvates, and hydrates of the compound, as well as their crystalline forms. The patent also covers pharmaceutical compositions containing these salts along with carriers or other therapeutic agents for the treatment of various conditions, including inflammatory diseases, autoimmune disorders, and cartilage-related conditions. Additionally, methods for preparing specific crystalline forms of the compound and for treating psoriatic arthritis in subjects using the disclosed salts are detailed in the claims.
The patent application outlines a comprehensive range of claims related to the formulation, composition, and therapeutic use of pharmaceutically acceptable salts of a compound according to Formula (I). These claims cover the creation of specific salt forms, their crystalline structures, and their application in pharmaceutical compositions for treating various medical conditions, particularly inflammatory and autoimmune diseases. The disclosed methods for preparing these salts in solid crystalline forms and the treatment of psoriatic arthritis in subjects using the salts, either alone or in combination with other therapeutic agents, provide a detailed insight into the potential applications of the compounds described in the patent.
To know more about GlobalData’s detailed insights on Galapagos, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
